Clinical Trial: Evaluation of the Safety and Efficacy of Nalbuphine for Early Analgesia in Severe Acute Pancreatitis: A Multicenter Randomized Controlled Trial (China)

Posted On: 2026-09-18

China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the Safety and Efficacy of Nalbuphine for Early Analgesia in Severe Acute Pancreatitis: A Multicenter Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132759

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: The Second Affiliated Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=312533

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Evaluation of the Safety and Efficacy of Nalbuphine for Early Analgesia in Severe Acute Pancreatitis: A Multicenter Randomized Controlled Trial (China)